Global Pertussis Vaccine Market By Type (Whole-cell vaccines, and Acellular vaccines), By Application (Children, and Adults), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 134611
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Pertussis Vaccine Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global pertussis vaccine market is segmented on the basis of Type, Application and geography.
The worldwide market for Pertussis Vaccine Market is expected to grow at a CAGR of roughly x.x% over the next ten years and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Pertussis Vaccine Market Scope:
By type, the market is segmented into Whole-cell vaccines?and Acellular vaccines. By Application, the market is divided into Children?and Adults. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Astellas Pharma, Minhai Biotechnology, Wuhan Institute of Biological Products?and Changchun Changsheng Life Sciences.
Key Market Segments
Type
Whole-cell vaccines
Acellular vaccinesApplication
Children
AdultsKey Market Players included in the report:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life SciencesReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Pertussis Vaccine Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Pertussis Vaccine Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Pertussis Vaccine Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Pertussis Vaccine Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Pertussis Vaccine Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Pertussis Vaccine Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Pertussis Vaccine sub-markets, depending on key regions (various vital states).
To analyze Pertussis Vaccine Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Pertussis Vaccine Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Pertussis Vaccine Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Pertussis Vaccine Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Pertussis Vaccine Market Overview3.1. Pertussis Vaccine Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Pertussis Vaccine Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Pertussis Vaccine Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Whole-cell vaccines
4.4. Acellular vaccines5. Global Pertussis Vaccine Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Pertussis Vaccine Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Children
5.4. Adults6. Global Pertussis Vaccine Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Pertussis Vaccine Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Pertussis Vaccine Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Pertussis Vaccine Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Pertussis Vaccine Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Pertussis Vaccine Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Pertussis Vaccine Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Sanofi Pasteur7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. GSK7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Mitsubishi Tanabe Pharma7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Astellas Pharma7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Minhai Biotechnology7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Wuhan Institute of Biological Products7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Changchun Changsheng Life Sciences7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
